Reduced-intensity conditioning for allogeneic stem-cell transplantation (SCT) with fludarabine and intravenous busulfan is associated with improved toxicity profile and longer survival than conditioning with fludarabine and melphalan in patients with chemo-sensitive hematological malignancies

被引：0
|
作者：
Shimoni, Avichai [1 ]
Hardan, Izhar [1 ]
Rand, Avital [1 ]
Shem-Tov, Noga [1 ]
Yerushalmi, Ronit [1 ]
Nagler, Arnon [1 ]
机构：
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2002
引用
收藏
页码：596A / 596A
页数：1
相关论文
共 50 条
  • [1] The combination of fludarabine and intravenous busulfan (IVFB) has a more favorable toxicity profile and overall outcome than fludarabine and melphalan (FM) as reduced-intensity conditioning prior to allogeneic stem-cell transplantation (SCT)
    Shimoni, A
    Yeshurun, M
    Hardan, I
    Shem-Tov, N
    Avigdor, A
    Ben-Bassat, I
    Nagler, A
    EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) : 61 - 61
  • [2] Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma
    Kekre, Natasha
    Marquez-Malaver, Francisco J.
    Cabrero, Monica
    Pinana, Jl
    Esquirol, Albert
    Soiffer, Robert J.
    Caballero, Dolores
    Terol, M. J.
    Martino, Rodrigo
    Antin, Joseph H.
    Lopez-Corral, L.
    Solano, Carlos
    Armand, Philippe
    Perez-Simon, Jose A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1808 - 1815
  • [3] Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies
    Kennedy, Vanessa E.
    Savani, Bipin N.
    Greer, John P.
    Kassim, Adetola A.
    Engelhardt, Brian G.
    Goodman, Stacey A.
    Sengsayadeth, Salyka
    Chinratanalab, Wichai
    Jagasia, Madan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1801 - 1807
  • [4] Choosing a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine/Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis
    Jain, Tania
    Alandab, Fares
    Firwana, Belal
    Sonbol, Mohamad Bassam
    Almader-Douglas, Diana
    Palmer, Jeanne
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) : 728 - 733
  • [5] Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis
    Yamamoto, Wataru
    Andou, Taiki
    Itabashi, Megumi
    Koyama, Satoshi
    Ishii, Yoshimi
    Numata, Ayumi
    Motohashi, Kenji
    Hagihara, Maki
    Matsumoto, Kenji
    Fujisawa, Shin
    INTERNAL MEDICINE, 2016, 55 (13) : 1721 - 1727
  • [6] Fludarabine phosphete and melphalan - An immunosuppressive reduced intensity conditioning (RIC) regimen for allogeneic stem cell transplantation in patients with a range of hematological malignancies
    Jackson, G
    Richardson, C
    Morgan, G
    Smith, G
    Johnson, P
    Davies, J
    Burnett, A
    Poynton, C
    Wilson, K
    Wareham, E
    Stars, A
    Tollerfield, S
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 15 - 18
  • [7] Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
    Lee, Seung-Shin
    Jung, Sung-Hoon
    Do, Young Rok
    Kim, Dae Sik
    Lee, Ji Hyun
    Park, Han-Seung
    Moon, Joon Ho
    Yi, Jun Ho
    Park, Yong
    Koh, Youngil
    Yhim, Ho-Young
    Choi, Yunsuk
    Mun, Yeung-Chul
    Lee, Won-Sik
    Lee, Seok
    Yang, Deok-Hwan
    YONSEI MEDICAL JOURNAL, 2020, 61 (06) : 452 - 459
  • [8] Fludarabine phosphate and melphalan - an immunosuppressive reduced intensity conditioning (RIC) regimen for allogeneic stem cell transplantation in patients with a range of hematological malignancies
    Jackson, G
    Richardson, C
    Morgan, G
    Smith, G
    Johnson, P
    Davies, J
    Burnett, A
    Poynton, C
    Wilson, K
    Wareham, E
    Stars, A
    Tollerfield, S
    BONE MARROW TRANSPLANTATION, 2002, 29 : S157 - S158
  • [9] Oral versus Intravenous Fludarabine as Part of a Reduced-Intensity Conditioning for Allogeneic Stem Cell Transplantation
    Velazquez-Sanchez-de-Cima, Sara
    Zamora-Ortiz, Gabriela
    Hernandez-Reyes, Jesus
    Daniel Rosales-Duron, Alan
    Patricia Gonzalez-Ramirez, Monica
    Angela Martagon-Herrera, Nora
    Ruiz-Delgado, Guillermo J.
    Ruiz-Argueelles, Guillermo J.
    ACTA HAEMATOLOGICA, 2014, 132 (01) : 125 - 128
  • [10] Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan
    Takuya Yamashita
    Akiyoshi Takami
    Naoyuki Uchida
    Takahiro Fukuda
    Tetsuya Eto
    Souichi Shiratori
    Shuichi Ota
    Takashi Akasaka
    Shigesaburo Miyakoshi
    Tadakazu Kondo
    Michihiro Hidaka
    Junya Kanda
    Yoshiko Atsuta
    Shingo Yano
    Bone Marrow Transplantation, 2020, 55 : 1955 - 1965
12345